Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
Abstract: The transcription factors STAT5a and STAT5b are constitutively active in many human tumors. Combined inhibition of both STAT5 proteins is a valuable approach with promising applications in tumor biology. We recently reported resorcinol bisphosphate as a moderately active inhibitor of the protein‐protein interaction domains, the SH2 domains, of both STAT5a and STAT5b. Here, we describe the development of resorcinol bisphosphate to Stafiba, a phosphatase‐stable inhibitor of STAT5a and STAT5b with activity in the low micromolar concentration range. Our data provide insights into the structure‐activity relationships of resorcinol bisphosphates and the corresponding bisphosphonates for use as inhibitors of both STAT5a and STAT5b.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor ; day:24 ; month:11 ; year:2022 ; extent:1
ChemBioChem ; (24.11.2022) (gesamt 1)
- Creator
-
Eckhardt, Katrin S.
Münzel, Theresa
Gräb, Julian
Berg, Thorsten
- DOI
-
10.1002/cbic.202200553
- URN
-
urn:nbn:de:101:1-2022112414484665854862
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eckhardt, Katrin S.
- Münzel, Theresa
- Gräb, Julian
- Berg, Thorsten
Other Objects (12)
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Small-Molecule Inhibitors of p53-MDM2 interactions
Development of STAT5a/b-specific small-molecule inhibitors
Extracellular and intracellular small-molecule galectin-3 inhibitors
Small-Molecule Inhibitors of the Tumor Suppressor Fhit
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
6 Small-Molecule Motion
Biochemical characterization of small-molecule inhibitors of protein-protein interactions
Small-molecule inhibitors of the transcription factors STAT5b and STAT5a
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Small-Molecule Inhibitors of p53-MDM2 interactions
Development of STAT5a/b-specific small-molecule inhibitors
Extracellular and intracellular small-molecule galectin-3 inhibitors
Small-Molecule Inhibitors of the Tumor Suppressor Fhit
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
6 Small-Molecule Motion
Biochemical characterization of small-molecule inhibitors of protein-protein interactions
Small-molecule inhibitors of the transcription factors STAT5b and STAT5a
A novel small-molecule MRCK inhibitor blocks cancer cell invasion
Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Small-Molecule Inhibitors of p53-MDM2 interactions
Development of STAT5a/b-specific small-molecule inhibitors
Extracellular and intracellular small-molecule galectin-3 inhibitors
Small-Molecule Inhibitors of the Tumor Suppressor Fhit
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
6 Small-Molecule Motion
Biochemical characterization of small-molecule inhibitors of protein-protein interactions
Small-molecule inhibitors of the transcription factors STAT5b and STAT5a
A novel small-molecule MRCK inhibitor blocks cancer cell invasion